alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
##### 



EXHIBIT 31.1
 CERTIFICATION PURSUANT TO 17 CFR 240.13(a)-14(a)
(SECTION 302 CERTIFICATION)
      a)
    
    Designed such disclosure controls and procedures or caused
such disclosure controls and procedures to be designed
under our supervision, to ensure that material information
relating to China Healthcare Acquisition Corp., including
its consolidated subsidiaries, is made known to us by
others within those entities, particularly during the
period in which this report is being prepared;b)
    
    Evaluated the effectiveness of China Healthcare Acquisition
Corp.s disclosure controls and procedures and presented in
this report our conclusions about the effectiveness of the
disclosure controls and procedures, as of the end of the
period covered by this report based on such evaluation; andc)
    
    Disclosed in this report any changes in China Healthcare
Acquisition Corp.s internal control over financial
reporting that occurred during China Healthcare Acquisition
Corp.s most recent fiscal year that has materially
affected, or is reasonably likely to materially affect,
China Healthcare Acquisition Corp.s internal control over
financial reporting.
  a)
    
    All significant deficiencies and material
weaknesses in the design or operation of internal
control over financial reporting which are
reasonably likely to adversely affect China
Healthcare Acquisition Corp.s ability to record,
process, summarize and report financial
information; andb)
    
    Any fraud, whether or not material, that involves
management or other employees who have a
significant role in China Healthcare Acquisition
Corp.s internal controls over financial
reporting.
 Date: August 14, 2007
    /s/ Alwin TanAlwin Tan, Chief Executive Officer
EXHIBIT 32.2 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title
18, United States Code), the undersigned officer of Sucampo Pharmaceuticals, Inc. (the Company) certifies to the best
of her knowledge that:  (1)
    
    The Quarterly Report on Form 10-Q for the period ended September 30, 2009 of the Company (the Report)
fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as
amended; and  (2)
    
    The information contained in the Report fairly presents, in all material respects, the financial
condition and results of operations of the Company. Date: November 6, 2009
    
    /s/ JAN SMILEKJan SmilekChief Financial Officer(Principal Financial and Accounting Officer)
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Justice

###### Antitrust Division

                    Notice is hereby given that, on May 22, 2009, pursuant to Section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301*et seq.*                     (“the Act”), The Association of Public-Safety Communications Officials International (“APCO”) has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing (1) the name and principal place of business of the standards development organization and (2) the nature and scope of its standards development activities. The notifications were filed for the purpose of invoking the Act's provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances.                

Pursuant to Section 6(b) of the Act, the name and principal place of business of the standards development organization is: The Association of Public-Safety Communications Officials International, Daytona Beach, FL. The nature and scope of APCO's standards development activities are: Public safety communications, including, but not limited to: training and professional development, professional qualifications, education, performance programs, technology, systems, operations, and other related issues.

Patricia A. Brink,

Deputy Director of Operations, Antitrust Division.

[FR Doc. E9-16781 Filed 7-15-09; 8:45 am]

BILLING CODE 4410-11-P
Case 2:11-cr-00405-KSH Document 10 Filed 01/05/12 Page 1 of 2 PageID: 24
Case 2:11-cr-00405-KSH Document 10 Filed 01/05/12 Page 2 of 2 PageID: 25
#### BUGEN et al. v. FRIEDMAN.

No. 10357.

United States District Court E. D. Pennsylvania.

June 13, 1950.

Elwood S. Levy, Philadelphia, Pa., for plaintiffs.

Philip H. Strubing, Philadelphia, Pa., 'for defendant.

McGRANERY, District Judge.

This is an action for damages against the defendant physician, alleging that serious injuries were sustained by the wife plaintiff as a result of the negligent manner in which the defendant is asserted to have performed a “nerve block”. Plaintiffs have filed interrogatories under Rule 33, F.R. C.P., 28 U.S.C.A., and to certain of them defendant objects.

Three of the interrogatories seek to require answers as to (1) whether the defendant assured the wife plaintiff that the treatment was without any serious risk, (2) whether he warned her of the possibility of complications, and (3) whether he obtained from either of the plaintiffs any written consent. Objection is taken to these questions on the ground of irrelevance. Rules 33 and 26(b), F.R.C.P. Only if .the cause of action were based upon an assault theory, contends the defendant, would they be relevant. However, it seems to me that the objections are not well taken, and that the interrogatories do go to the issue of negligence. If the answer to the first is in the affirmative, an inference of negligence is possible. If the answer to the second is in the negative, a separate inference of negligence is possible. And the answer to the third question may support an inference which may be drawn from either of the other two answers.

*232A fourth interrogatory objected to asks the defendant to state, if he charges contributory negligence, upon what conduct, acts, or omissions of the plaintiffs such charge is based. The plaintiffs urge that the subject matter of the accident involves technical, medical and anatomical data which would be known or should be known to a physician such as the defendant and which obviously would not be within the knowledge of the wife plaintiff, and furthermore, the wife plaintiff was, for the performance of the “nerve block”, exclusively under the control of the defendant. Consequently, it is argued, the plaintiffs are entitled to learn any facts which, for these reasons, are in the knowledge of the defendant. I am in thorough agreement with this contention, but the plaintiffs have asked too much. They have asked for the expression of a conclusion and an opinion, Ryan v. Lehigh Valley R. Co., D.C., 5 F.R.D. 399; Doucette v. Howe, D.C., 1 F.R.D. 18; Doucette v. Eastern State Transportation Co., Inc., D.C., 1 F.R.D. 66; and not merely for the expression of an expert medical opinion, cf. Kendall v. United Air Lines, D.C., 9 F.R.D. 702. I believe that the desired facts can be ascertained by properly phrased interrogatories or requests for admissions. They cannot, however, be required from the defendant under the shotgun query of contributory negligence.
## F IRST 

## D ISTRICT 

## C OURT OF 

## A PPEAL 

## S TATE OF 

## F LORIDA

_____________________________
No. 1D 2 0 2 3

- 2981

_____________________________
J OSEPH M ICHAEL D AVIS ,
Petitioner
,

v.

S TATE OF F LORIDA , Respondent

.

_____________________________

Petition for Writ of Prohibition

— Original Jurisdiction

.

January 23, 2024

P ER C URIAM

.
D ISMISSED

.
L EWIS , R AY , and L ONG , JJ., concur.

_____________________________ Not final until disposition of any timely and authorized motion under Fla. R. App. P. 9.330 or 9.331

.

_____________________________

Joseph Michael Davis
, pro se, Petitioner

.2 Ashley Moody, Attorney General, Tallahassee
, for Respondent

.
[Federal Register Volume 74, Number 134 (Wednesday, July 15, 2009)]
[Notices]
[Page 34323]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-16722]



[[Page 34323]]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Project No. 13476-000]


FFP Project 65, LLC; Notice of Preliminary Permit Application 
Accepted for Filing and Soliciting Comments, Motions To Intervene, and 
Competing Applications

July 8, 2009.
    On May 22, 2009, FFP Project 65, LLC filed an application for a 
preliminary permit, pursuant to section 4(f) of the Federal Power Act, 
proposing to study the feasibility of the Jackson Point Hydrokinetic 
Project, to be located on the Mississippi River, in Concordia Parish, 
Louisiana and Adams County, Mississippi.
    The sole purpose of a preliminary permit, if issued, is to grant 
the permit holder priority to file a license application during the 
permit term. A preliminary permit does not authorize the permit holder 
to perform any land disturbing activities or otherwise enter upon lands 
or waters owned by others without the owners' express permission.
    The proposed Jackson Point Hydrokinetic Project consists of: (1) 
4,435 proposed 40 kilowatt Free Flow generating units having a total 
installed capacity of 177.40 megawatts; (2) a 6-mile-long, 69 kilovolt 
transmission line; and (3) appurtenant facilities. The proposed Jackson 
Point Hydrokinetic Project would have an average annual generation of 
777 gigawatt-hours.
    Applicant Contact: Ramya Swaminathan, Vice President of 
Development, Free Flow Power Corporation, 33 Commercial Street, 
Gloucester, MA 01930; phone: (978) 226-1531.
    FERC Contact: Kim Carter, 202-502-6486.
    Deadline for filing comments, motions to intervene, competing 
applications (without notices of intent), or notices of intent to file 
competing applications: 60 days from the issuance of this notice. 
Comments, motions to intervene, notices of intent, and competing 
applications may be filed electronically via the Internet. See 18 CFR 
385.2001(a)(1)(iii) and the instructions on the Commission's Web site 
under the ``e-Filing'' link. If unable to be filed electronically, 
documents may be paper-filed. To paper-file, an original and eight 
copies should be mailed to: Kimberly D. Bose, Secretary, Federal Energy 
Regulatory Commission, 888 First Street, NE., Washington, DC 20426. For 
more information on how to submit these types of filings please go to 
the Commission's Web site located at http://www.ferc.gov/filing-comments.asp. More information about this project, including a copy of 
the application, can be viewed or printed on the ``eLibrary'' link of 
Commission's Web site at http://www.ferc.gov/docs-filing/elibrary.asp. 
Enter the docket number (P-13476) in the docket number field to access 
the document. For assistance, call toll-free 1-866-208-3372.

Kimberly D. Bose,
Secretary.
 [FR Doc. E9-16722 Filed 7-14-09; 8:45 am]
BILLING CODE 6717-01-P
Case 1:11-cv-02658-JBS-KMW Document 1 Filed 05/10/11 Page 1 of 11 PageID: 1
Case 1:11-cv-02658-JBS-KMW Document 1 Filed 05/10/11 Page 2 of 11 PageID: 2
Case 1:11-cv-02658-JBS-KMW Document 1 Filed 05/10/11 Page 3 of 11 PageID: 3
Case 1:11-cv-02658-JBS-KMW Document 1 Filed 05/10/11 Page 4 of 11 PageID: 4
Case 1:11-cv-02658-JBS-KMW Document 1 Filed 05/10/11 Page 5 of 11 PageID: 5
Case 1:11-cv-02658-JBS-KMW Document 1 Filed 05/10/11 Page 6 of 11 PageID: 6
Case 1:11-cv-02658-JBS-KMW Document 1 Filed 05/10/11 Page 7 of 11 PageID: 7
Case 1:11-cv-02658-JBS-KMW Document 1 Filed 05/10/11 Page 8 of 11 PageID: 8
Case 1:11-cv-02658-JBS-KMW Document 1 Filed 05/10/11 Page 9 of 11 PageID: 9
Case 1:11-cv-02658-JBS-KMW Document 1 Filed 05/10/11 Page 10 of 11 PageID: 10
Case 1:11-cv-02658-JBS-KMW Document 1 Filed 05/10/11 Page 11 of 11 PageID: 11
Exhibit10(r)


Exhibit 10(r)


ENERGEN CORPORATION STOCK INCENTIVE PLAN
STOCK OPTION AGREEMENT
 [Incentive Stock Option / Nonqualified Stock Option] 
Dated as of ____________,_____






A stock option is hereby granted to the below named Participant.  This option is granted under the Energen Corporation Stock Incentive Plan (“the Plan”), as amended, and is subject in all respects to the terms and provisions of the Plan which is incorporated herein by reference.  Without limiting the generality of the foregoing, this option is subject to the exercise and transferability restrictions set forth in the Plan.  Words defined in the Plan and used in this Agreement shall have the meanings set forth in the Plan.  The attributes of this option are as follows:


	
					
	1)
	Incentive Stock Option:  This option is a[n] [ Incentive Stock Option / Nonqualified Stock Option ].

	 
	 
	 
	 
	 

	2)
	Participant:    «Name»
	 
	 
	 

	 
	 
	 
	 
	 

	3)
	Shares subject to option:    «Shares»
	4)
	Grant Date:    ___________

	 
	 
	 
	 

	5)
	Exercise Price per share:    $_____
	6)
	Expiration Date:     ___________

	 
	 

	7)
	Vesting: The option shall become exercisable on [ 100% on a specified date / in increments on specified dates ].   Any exercisable portion of the option may be exercised in full or, from time to time, in increments of at least 100 shares.

	 
	 

	8)
	SARs: This option [ does / does not ] include stock appreciation rights (see Plan Section 6.2(i)), [but such stock  appreciation rights are payable only in shares of stock, they are not payable in cash].

	 
	 

	9)
	Additional terms and conditions:    [ None /  specified additional terms and conditions ].








	
				
	ENERGEN CORPORATION
	 
	The Participant hereby accepts this option and
agrees to accept as binding, conclusive, and
and final all decisions and interpretations of 
the Committee and/or the Board, upon any
questions arising under the Plan.

	 
	 
	 
	 

	By:
	 
	 
	 

	Its:
	 
	 
	 

	 
	 
	 
	 

	 
	 
	 
	Participant - «Name»
UNITED STATES DISTRICT COURT

DISTRICT OF NEW JERSEY

UNITED STATES OF AMERICA

Crim. No. 11-366 (JLL)

V.

JOHN ALFY SALAMA MARKUS,

a/k/a “John Salama,” : PROTECTIVE ORDER ON CONSENT

a/k/a “John Alfy Salama”

This application having been opened to the Court by the

United States Attorney (Sandra L. Moser, Assistant U.S. Attorney,

appearing) under Rule 16(d) (1) of the Federal Rules of Criminal

Procedure for a protective order limiting the disclosure of the

contents of electronic files recovered from servers maintained by

the Department of Defense, Department of the Army, United States

Army Corps of Engineers (“USACE”) in Tikrit, Iraq (hereinafter,

the “USACE electronic files”), and which have been or will be

made available to counsel for defendant John Alfy Salama Markus

(Michael Rogers, Esq., appearing), and the Court, having the

consent of the parties, and for good cause shown,

IT IS on this frj day of May, 2012,

ORDERED that:

1. The USACE electronic files shall not be disclosed to

anyone other than the defendant, the defendant’s

counsel, and any agent working at the direction of

defense counsel in this matter;

2. The USACE electronic files and information contained in

the USACE electronic files, only will be used in the

Case 2:11-cr-00366-JLL Document 39 Filed 05/30/12 Page 1 of 2 PageID: 205
preparation of the defense in this case and

notwithstanding the provisions of Paragraph 1, the

defense shall be permitted to review, with prospective

witnesses and their counsel, all materials referenced

in Paragraph 1 to the extent necessary to prepare the

defense;

3. Notwithstanding any other provision, the defendant

shall be permitted to disclose any materials provided

in Paragraph 1 in connection with the filing of the

defendant’s motions with the Court, or for use at

trial, subject to Fed. R. Crim. P. 41.1; and

4. If there is a need prior to trial or during trial to

disclose the USACE electronic files or information

contained in the USACE electronic files, beyond that

permitted by this Order, then the defendant will make

an application to the Court upon notice to the

government, requesting authorization.

)SE L. LINARES

STATES DISTRICT JUDGE

Case 2:11-cr-00366-JLL Document 39 Filed 05/30/12 Page 2 of 2 PageID: 206
[Federal Register Volume 74, Number 135 (Thursday, July 16, 2009)]
[Notices]
[Page 34583]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-16894]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Amended Notice of Meeting

    Notice is hereby given of a change in the meeting of the National 
Cancer Institute Special Emphasis Panel, July 22, 2009, 8 a.m.to July 
23, 2009, 5 p.m., Marriott Bethesda North Hotel & Conference Center, 
Bethesda, MD which was published in the Federal Register on June 11, 
2009, 74FR27806.
    This notice is amended to change the title from ``NCI-ARRA 
Competitive Revisions-Pre Clinical, Drug Discovery & Imaging'' to 
``NCI-ARRA Competitive Revisions & Grand Opportunity-Pre Clinical, Drug 
Discovery & Imaging''. The meeting is closed to the public.

    Dated: July 9, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-16894 Filed 7-15-09; 8:45 am]
BILLING CODE 4140-01-P
```

[Congressional Bills 108th Congress]
[From the U.S. Government Publishing Office]
[H.R. 5151 Introduced in House (IH)]

108th CONGRESS
  2d Session
                                H. R. 5151

  To transfer administrative jurisdiction over certain land in Clark 
County, Nevada, from the Secretary of the Interior to the Secretary of 
                           Veterans Affairs.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                           September 28, 2004

 Mr. Porter (for himself, Mr. Gibbons, and Ms. Berkley) introduced the 
    following bill; which was referred to the Committee on Resources

_______________________________________________________________________

                                 A BILL

 
  To transfer administrative jurisdiction over certain land in Clark 
County, Nevada, from the Secretary of the Interior to the Secretary of 
                           Veterans Affairs.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Foundation for Nevada's Veterans 
Land Transfer Act of 2004''.

SEC. 2. TRANSFER OF ADMINISTRATIVE JURISDICTION, BUREAU OF LAND 
              MANAGEMENT LAND, CLARK COUNTY, NEVADA.

    (a) In General.--Administrative jurisdiction over the land 
described in subsection (b) is transferred from the Secretary of the 
Interior to the Secretary of Veterans Affairs.
    (b) Description of Land.--The parcel of land referred to in 
subsection (a) is the approximately 150 acres of Bureau of Land 
Management land in Clark County, Nevada, as generally depicted on the 
map entitled ``Veterans Administration Conveyance'' and dated September 
24, 2004.
    (c) Use of Land.--The parcel of land described in subsection (b) 
shall be used by the Secretary of Veterans Affairs for the construction 
and operation of medical and related facilities, as determined to be 
appropriate by the Secretary of Veterans Affairs.
                                 <all>
```
**Exhibit        32.1**

**CERTIFICATION        PURSUANT TO**

**18        U.S.C., SECTION 1350,**

**AS        ADOPTED PURSUANT TO**

|                                     |                                                                                                                          |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|                                     | **TIDELANDS                OIL & GAS CORPORATION**                                                                        |
|                                |                                                                                                                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| Date: April                17, 2007 | By:                                                                                                                 | /s/ James                B.                Smith                                                                                |
|                                     | James B. Smith, President, CEO (Principal                Executive Officer), CFO (Principal Financial and Accounting Officer) |
|                                     |                                                                                                                          |

----